Marie Picot

Rouen, 76000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Whole body distribution of the regulatory peptide 26RFa in male and female mice.

Whole body distribution of the regulatory peptide 26RFa in male and female mice.

Journal: Peptides

Published: March 21, 2025

Glucose and energy metabolism are impaired in mice deficient for orexins.

Glucose and energy metabolism are impaired in mice deficient for orexins.

Journal: The Journal of endocrinology

Published: November 20, 2024

Serum levels of the incretin-like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa-Ba-S study.

Serum levels of the incretin-like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa-Ba-S study.

Journal: Diabetes, obesity & metabolism

Published: May 13, 2024

The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism.

The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism.

Journal: Neuroendocrinology

Published: November 30, 2023

Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy.

Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 01, 2023

Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient mice.

Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient mice.

Journal: Neuropeptides

Published: November 21, 2022

The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.

The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.

Journal: Diabetologia

Published: January 07, 2022

Acute but Not Chronic Central Administration of the Neuropeptide 26RFa (QRFP) Improves Glucose Homeostasis in Obese/Diabetic Mice.

Acute but Not Chronic Central Administration of the Neuropeptide 26RFa (QRFP) Improves Glucose Homeostasis in Obese/Diabetic Mice.

Journal: Neuroendocrinology

Published: September 30, 2021

Point-Substitution of Phenylalanine Residues of 26RFa Neuropeptide: A Structure-Activity Relationship Study.

Point-Substitution of Phenylalanine Residues of 26RFa Neuropeptide: A Structure-Activity Relationship Study.

Journal: Molecules (Basel, Switzerland)

Published: June 07, 2021

Glucose homeostasis is impaired in mice deficient in the neuropeptide 26RFa (QRFP).

Glucose homeostasis is impaired in mice deficient in the neuropeptide 26RFa (QRFP).

Journal: BMJ open diabetes research & care

Published: October 09, 2019

The neuropeptide 26RFa in the human gut and pancreas: potential involvement in glucose homeostasis.

The neuropeptide 26RFa in the human gut and pancreas: potential involvement in glucose homeostasis.

Journal: Endocrine connections

Published: June 07, 2019

Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice.

Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice.

Journal: American journal of physiology. Endocrinology and metabolism

Published: May 16, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026